or Try an Advanced Search...

    Vascular Disease Stocks List

    Symbol Grade Name % Change
    SMLR F Semler Scientific, Inc. -25.29
    AMRN C Amarin Corporation plc -11.51
    OCUP F Ocuphire Pharma, Inc. -5.67
    MESO B Mesoblast Limited -4.59
    ANGO C AngioDynamics, Inc. -4.07
    KOD D Kodiak Sciences Inc -3.77
    NBIX B Neurocrine Biosciences, Inc. -2.91
    MMSI B Merit Medical Systems, Inc. -1.65
    CAPR D Capricor Therapeutics, Inc. -1.65
    REGN C Regeneron Pharmaceuticals, Inc. -1.46
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Cardiovascular Disease Inflammation Medicine Diabetes Organ Systems Angiogenesis Angiology Biotechnology Cancer Diabetic Retinopathy Disease Eye Heart Disease Hypertension Influenza Irritable Bowel Syndrome Life Sciences Macular Degeneration Ophthalmology Respiratory Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Vascular Disease stocks.

    Symbol Grade Name Weight
    IHI D iShares U.S. Medical Devices ETF 16.76
    PJP A PowerShares Dynamic Pharmaceuticals 8.8
    IBB D iShares Nasdaq Biotechnology Index Fund 7.85
    IBBQ C Invesco Nasdaq Biotechnology ETF 7.81
    BIS D ProShares UltraShort Nasdaq Biotechnology 7.65
    View all Vascular Disease ETFs...
    Compare ETFs
    Compare IBBQ to BIS Compare PJP to BIS Compare PJP to IBBQ

        Vascular Disease Stocks Recent News

        Date Stock Title
        May 8 SMLR Semler Scientific: Great Product Can Still Thrive Post Medicare Advantage
        May 8 SMLR Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2024 Earnings Call Transcript
        May 8 CAPR Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
        May 8 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
        May 8 REGN Regeneron gene therapy improves hearing in child deafness
        May 8 REGN Regeneron gene therapy improves hearing in two children
        May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
        May 7 SMLR Semler Scientific, Inc. (SMLR) Q1 2024 Earnings Call Transcript
        May 7 SMLR Semler Scientific Inc (SMLR) Q1 Earnings: Mixed Results Amid Revenue Decline and Net Income Growth
        May 7 SMLR Semler Scientific GAAP EPS of $0.78 misses by $0.25, revenue of $15.9M misses by $5.5M
        May 7 NBIX Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference
        May 7 SMLR Semler Scientific® Reports First Quarter 2024 Financial Results
        May 7 NBIX Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024
        May 6 SMLR Semler Scientific Q1 2024 Earnings Preview
        May 6 ANGO AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
        May 6 REGN Regeneron Announces Investor Conference Presentations
        May 6 REGN Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
        May 6 MMSI Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
        May 6 CAPR Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
        May 6 NBIX Neurocrine Biosciences Supports Tardive Dyskinesia Awareness Week by Advocating for Routine Screening and Monitoring
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Cardiovascular Disease Medicine Hypertension Biopharmaceutical Biotechnology Cancer Cardiovascular System Catheter Diabetes Heart Disease Heart Failure Infectious Diseases Inflammation Influenza Irritable Bowel Syndrome Life Sciences Perfusion S&P 500 Veins Acne
        Vascular Disease

        Vascular disease is a term used to describe any condition that affects the circulatory system, including the arteries, veins, and capillaries. It can be caused by a variety of factors, including high blood pressure, high cholesterol, smoking, diabetes, and obesity. Vascular diseases can lead to serious health complications, such as stroke, heart attack, and peripheral artery disease.

        Browse All Tags